跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,184 条关于
“Duomed Belgium NV”
全部
1,184
临床试验
411
药物
150
机构
91
资讯
532
去年
Avacta Therapeutics Sells Launch Diagnostics for £12.9M to Focus on Cancer Drug Development
4个月前
UCB Opens €200 Million Gene Therapy Manufacturing Facility in Belgium
2年前
NanoViricides' NV-387 Shows Broad-Spectrum Antiviral Activity Against 'Tripledemic' Viruses and Smallpox in Animal Models
3年前
Avacta Acquires Belgium-Based Coris BioConcept for £7.4 Million to Expand Diagnostics Portfolio
2年前
NanoViricides Develops First-In-Class Broad-Spectrum Antiviral Agent NV-387
去年
NanoViricides' NV-387 Advances to Phase II Clinical Trials for MPox Treatment
去年
NanoViricides Advances NV-387 to Phase II Trials Targeting MPox and Respiratory Infections
去年
NanoViricides Advances NV-387 for Herpes Zoster Treatment to Phase II Trials
去年
NanoViricides' NV-387 Advances to Phase II Trials for Multiple Viral Infections
去年
NanoViricides Advances NV-387 as Potential Treatment for Measles Amid Declining Vaccination Rates
第 1 页,共 54 页
上一页
下一页